Lung Cancer

Michael O'Leary

Immunotherapy before and after surgery improved lung cancer outcomes

CANCER DIGEST -- Oct. 27, 2023 -- Lung cancer patients who underwent immunotherapy before and after surgery had a 32 percent lower risk...

Michael O'Leary

New drug boosts disease-free survival in NSCLC

May represent a treatment shift to earlier use of targeted therapy against EGFR cancer CANCER DIGEST – Feb. 11, 2023 – Non-small cell...

Michael O'Leary

Drug for rare lung cancer receives FDA approval

CANCER DIGEST – Jan. 7, 2023 – The US FDA has approved a new treatment for a rare type of lung cancer following a clinical trial led by...